If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTristel Regulatory News (TSTL)

Share Price Information for Tristel (TSTL)

Share Price is delayed by 15 minutes
Get Live Data
400.00    0.00 (0.00%)
Bid:
395.00
Ask:
405.00
Spread: 10.00 (2.532%)
Market Cap: £191.99m
TSTL Live PriceLast checked at - London Stock Exchange

Intraday Tristel Share Chart

Investor results presentation

21 Aug 2019 07:00

RNS Number : 6759J
Tristel PLC
21 August 2019
 

21 August 2019 

Tristel plc 

("Tristel" or the "Company") 

 

Investor results presentation 

 

Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, will announce the Company's full year results for the year ended 30 June 2019 on Wednesday 16 October 2019.

 

Investor presentations 

Paul Swinney, CEO, and Liz Dixon, CFO, will present the Company's results in two separate events open to all investors. The same presentation will be given at both events which are being held at different times to offer convenient options for those wishing to attend. 

 

Two presentations will take place on Wednesday 16 October 2019 at the following times and location: 

·; 10.30 for a 10.45 start at The Brand Exchange, 3 Birchin Ln, London, EC3V 9BW 

·; 16.45 for a 17.00 start at No. 1 Cornhill, London, EC3V 3ND

 

The presentations will be followed by refreshments.  

 

If you would like to register for either investor presentation, or require further information, please contact Lianne Cawthorne at Walbrook PR on 020 7933 8780 or email tristel@walbrookpr.com ensuring you detail in your email which presentation you would like to attend. 

 

The results presentation will be made available on the Company's website www.tristel.com on the day of results. 

 

 

For further information please contact:  

 

 

Tristel plc 

Tel: 01638 721 500 

Paul Swinney, Chief Executive Officer 

Liz Dixon, Finance Director 

Walbrook PR Ltd 

Tel: 020 7933 8780 or tristel@walbrookpr.com 

Paul McManus 

Mob: 07980 541 893 

Lianne Cawthorne 

Mob: 07584 391 303 

finnCap 

Geoff Nash/ Giles Rolls (Corporate Finance) 

Tel: 020 7220 0500 

Alice Lane (ECM) 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAURSORKKAWUAR
Date   Source Headline
23rd Apr 20187:00 amRNSEPA approval received
13th Apr 20182:55 pmRNSIssue of Equity
27th Mar 20188:19 amRNSIssue of Equity
26th Mar 20187:00 amRNSCommercial collaboration with Parker Laboratories
8th Mar 201810:58 amRNSIssue of Equity
20th Feb 20187:00 amRNSHalf-year Report
8th Feb 20182:19 pmRNSHolding(s) in Company
26th Jan 20187:00 amRNSIssue of Equity
24th Jan 20187:00 amRNSStudy shows comparable efficacy of Tristel Wipes
17th Jan 20187:00 amRNSInvestor results presentation
12th Dec 20172:57 pmRNSResult of AGM
12th Dec 20177:00 amRNSAGM Statement & notice of results
27th Nov 201710:35 amRNSIssue of Equity
23rd Nov 20173:24 pmRNSClarification of AGM timing
14th Nov 201710:34 amRNSIssue of Equity
2nd Nov 20177:00 amRNSDirectors dealing/grant of options
23rd Oct 20174:41 pmRNSIssue of Equity
19th Oct 20177:01 amRNSDirector Appointment
19th Oct 20177:00 amRNSFinal Results
3rd Oct 20177:00 amRNSTiming of EPA approval
19th Sep 20177:00 amRNSInvestor results presentation
18th Sep 20171:44 pmRNSIssue of Equity
22nd Aug 201712:08 pmRNSIssue of Equity
18th Aug 20171:31 pmRNSDirector/PDMR Dealing - replacement
17th Aug 20177:00 amRNSDirector/PDMR Dealing
7th Aug 20172:29 pmRNSIssue of Equity
24th Jul 20179:46 amRNSIssue of Equity
19th Jul 20177:00 amRNSTrading update & Notice of results
5th Jul 20177:00 amRNSIssue of Equity
3rd Jul 20171:59 pmRNSStrategic investment
3rd Jul 20177:00 amRNSSubmission to EPA & subsidiary incorporated in USA
13th Jun 20177:00 amRNSIssue of Equity
24th May 20177:00 amRNSShareholder Open Day & Notice of Trading Update
19th May 20173:34 pmRNSIssue of Equity
3rd May 20178:27 amRNSIssue of Equity
7th Apr 20175:04 pmRNSResult of Placing
7th Apr 20172:07 pmRNSProposed Secondary Placing
28th Mar 20172:38 pmRNSIssue of Equity
7th Mar 20179:41 amRNSIssue of Equity
6th Mar 20177:00 amRNSIssue of Equity
27th Feb 20177:00 amRNSProducts approved by Australia's TGA
27th Feb 20177:00 amRNSJournal of Ultrasound in Medicine & Biology
23rd Feb 20177:00 amRNSHalf-year Report
25th Jan 20177:00 amRNSInvestor results presentation
24th Jan 20177:00 amRNSJournal of Infection Prevention: TSTL wipes study
17th Jan 201712:31 pmRNSDirector / PDMR Shareholding
13th Dec 201612:30 pmRNSResult of AGM
13th Dec 20167:00 amRNSAGM Statement
6th Dec 20167:00 amRNSIssue of Equity
28th Nov 20163:42 pmRNSNotice of AGM correction

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.